|
시장보고서
상품코드
2077378
글루코스 바이오센서 시장 : 기술별, 용도별, 최종 용도별, 지역별Global Glucose Biosensor Market, By Technology, By Application, By End Use, By Geography |
||||||
세계의 글루코스 바이오센서 시장은 2026년에 127억 4,000만 달러로 추정되며, 2033년까지 219억 8,000만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 8.1%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 127억 4,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 8.10% | 2033년 시장 규모 예측: | 219억 8,000만 달러 |
전 세계 글루코스 바이오센서 시장은 예측 기간 동안 상당한 성장률을 보이며 확대될 전망입니다. 글루코스 바이오센서란, 생체 시료 내의 포도당 농도를 검출하기 위해 사용되는 분석 장치입니다. 이 장치에는 포도당 산화효소나 포도당 결합 단백질 등의 생체인식 소자가 내장되어 있습니다. 이 생체인식 소자는 생물학적 현상을 정량 가능한 분석 신호로 변환하는 물리화학적 변환기 위에 고정화되어 있습니다. 당뇨병 유병률의 증가와 자가 측정 및 재택 관리에 관한 엄격한 규제 프로토콜이 이 시장의 성장을 이끄는 주요 요인으로 작용하고 있습니다. 최소침습적이고 저비용이면서도 고정밀도로 사용하기 편리한 바이오센서 개발 분야의 기술적 진보에 힘입어, 진료 현장과 가정에서의 활용이 가속화되고 있습니다.
시장 역학:
전 세계 글루코스 바이오센서 시장의 성장은 고령 인구 증가와 전 세계 당뇨병 발병률 상승에 힘입어 이루어지고 있습니다. 국제당뇨병연맹(IDF)에 따르면, 2020년에는 약 4억 6,300만 명의 성인(20-79세)이 당뇨병을 앓고 있었으며, 이 숫자는 2045년까지 7억 명으로 증가할 것으로 예측됩니다. 이로 인해 혈당 자가 측정 수요가 크게 증가하고 있습니다. 또한, 유리한 보험 환급 정책과 자가 측정을 장려하기 위한 정부의 노력이 시장 성장에 박차를 가하고 있습니다. 그러나 규제 당국의 엄격한 승인 요건과 바이오센서와 관련된 높은 비용이 예측 기간 동안 시장 확대를 어느 정도 저해할 것으로 예상됩니다. 한편, 웨어러블 방식이며 비침습적이고 스마트폰과 연동 가능한 바이오센서 개발을 위한 지속적인 연구 개발이 새로운 가능성을 열어가고 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 글루코스 바이오센서 시장의 주요 기업 개요을 소개하고 있습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 글루코스 바이오센서 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 글루코스 바이오센서 시장 : 기술별, 2021-2033년
제5장 세계의 글루코스 바이오센서 시장 : 용도별, 2021-2033년
제6장 세계의 글루코스 바이오센서 시장 : 최종사용자별, 2021-2033년
제7장 세계의 글루코스 바이오센서 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.07.08Global Glucose Biosensor Market is estimated to be valued at USD 12.74 Bn in 2026 and is expected to reach USD 21.98 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.74 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.10% | 2033 Value Projection: | USD 21.98 Bn |
The global glucose biosensor market is poised to grow at a significant rate over the forecast period. A glucose biosensor is an analytical device used for the detection of glucose concentration in biological samples. It incorporates a bio-recognition element like glucose oxidase enzyme or glucose-binding protein. The bio-recognition element is immobilized on a physicochemical transducer that transforms the biological event into a quantifiable analytical signal. Increased prevalence of diabetes and stringent regulatory protocols related to self-monitoring and homecare are the key factors driving the growth of this market. Technological advancements in developing minimally invasive, low-cost, accurate, and user-friendly biosensor have accelerated their adoption in point-of-care and home-use applications.
Market Dynamics:
The growth of the global glucose biosensor market is driven by rising geriatric population and increasing incidence of diabetes across the world. As per the International Diabetes Federation, around 463 million adults (20-79 years) were living with diabetes in 2020 and the number is projected to increase to 700 million by 2045. This has significantly increased the demand for self-monitoring of blood glucose. Moreover, favorable reimbursement policies and government initiatives to promote self-monitoring are providing impetus to the market growth. However, stringent regulatory approvals and high costs associated with biosensor are expected to hinder the market expansion to some extent during the forecast period. On the positive side, ongoing R&D to develop wearable, non-invasive, and smartphone integrated biosensor opens new avenues.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global glucose biosensor market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott Laboratories, Dexcom, Ascenia Diabetes Care, Nova Diabetes Care, F. Hoffmann-La Roche Ltd., Sanofi, GlySens Incorporated, Trividia Health, Bayer, and Lifescan.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global glucose biosensor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glucose biosensor market.
Detailed Segmentation:
- Global Glucose Biosensor Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Enzymatic Biosensor
- Non-Enzymatic Biosensor
- Global Glucose Biosensor Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Home Diagnostics
- Hospitals and Clinics
- Research and Development
- Global Glucose Biosensor Market, By End Use (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Homecare
- Diagnostic centers
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Glucose Biosensor Market:
- Abbott Laboratories
- Dexcom
- Ascenia Diabetes Care
- Nova Diabetes Care
- Hoffmann-La Roche Ltd.
- Sanofi
- GlySens Incorporated
- Trividia Health
- Bayer
- Lifescan
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising prevalence of diabetes
- Growing geriatric population
- Stringent regulatory policies
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Product Launches
- Mergers, Acquisitions, and Collaborations
4. Global Glucose Biosensor Market, By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Enzymatic Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Non-Enzymatic Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Glucose Biosensor Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Home Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Glucose Biosensor Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diagnostic centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Glucose Biosensor Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profile
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dexcom
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ascenia Diabetes Car Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nova Diabetes Care
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F.Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlySens Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Trividia Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lifescan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott Laboratories
- Analyst Views
9. Section
- References
- Research Methodology
- About us
